Tajikistan’s pharma output expands in early 2026
Photo: Agency for Protection and Development of Competition of the Republic of Kazakhstan
The moderation in pharmaceutical output growth suggests a normalization after last year’s surge, pointing to stabilizing demand and a more balanced expansion of the sector within the broader industrial structure.
Access to paid information is limited
If You already have an account, please log in
Subscription to paid content
Gain access to all that Trend has to offer, as well as to premium, licensed content via subscription or direct purchase through a credit card.
